Cargando…
Quantification of TFF3 expression from a non-endoscopic device predicts clinically relevant Barrett's oesophagus by machine learning
BACKGROUND: Intestinal metaplasia (IM) is pre-neoplastic with variable cancer risk. Cytosponge-TFF3 test can detect IM. We aimed to 1) assess whether quantitative TFF3 scores can distinguish clinically relevant Barrett's oesophagus (BO) (C≥1 or M≥3) from focal IM pathologies (C<1, M<3 or...
Autores principales: | Berman, Adam G., Tan, W. Keith, O'Donovan, Maria, Markowetz, Florian, Fitzgerald, Rebecca C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297109/ https://www.ncbi.nlm.nih.gov/pubmed/35843173 http://dx.doi.org/10.1016/j.ebiom.2022.104160 |
Ejemplares similares
-
Methylation panel is a diagnostic biomarker for Barrett’s oesophagus in endoscopic biopsies and non-endoscopic cytology specimens
por: Chettouh, Hamza, et al.
Publicado: (2018) -
Real-world implementation of non-endoscopic triage testing for Barrett’s oesophagus during COVID-19
por: Landy, R, et al.
Publicado: (2023) -
Update on endoscopic treatment of Barrett’s oesophagus and Barrett’s oesophagus–related neoplasia
por: Pech, Oliver, et al.
Publicado: (2020) -
Barrett's oesophagus and adenocarcinoma
por: Caygill, Christine PJ, et al.
Publicado: (2004) -
Screening for Barrett’s Oesophagus: Are We Ready for it?
por: Yusuf, Aisha, et al.
Publicado: (2021)